Opinions

The best advice appears to be: bet on the vaccinations to work, keep monitoring the global economy and keep an eye on gasoline demand.

During July, Federal Reserve Chairman Jerome Powell mentioned his concerns about labor market growth twice in his public speeches.

We may have seen emerging signs that stock market and gold traders are banking on dampened fears over inflation, Fed easing policy.

The unexpectedly hawkish message delivered by the Fed last week took the markets by surprise, with cable one of the big losers.

The policy paths of the BoE and the Fed now appear to be diverging.

This time the jump in yields is different. This time, the professionals have evidence of inflation.

The price of bitcoin tumbled over the weekend and was down as much as 19.5% from record highs posted by the popular cryptocurrency in the past week.

Stock market investors may stop viewing higher yields as a detriment, but rather a sign that the economy is heating up. And that’s a good thing.

Meanwhile, oil has a decent chance to gain more upside momentum after OPEC+ decided to gradually increase production.

We sat down with Craig Allison and asked him 5 questions about the forex industry and FP Markets.

Oil will also be in traders’ focus amid rising tensions in the Middle East.

Monetary stimulus from Fed and fiscal stimulus from Washington present powerful tailwinds for GDP this year.

While vaccination rates tick up, some of the world’s largest economies are continuing to lag. Vaccine shortages will remain a key area of concern.

Amidst low vaccination rates across the bloc, the Euro area receives more bad news on the vaccine front. Containment measures are unlikely to ease soon.

As the COVID-19 pandemic rages on and economies suffer, the need for a single dose vaccine becomes even greater. Economic divergence is to be exptected.

Ireland looks to get ahead by securing AstraZeneca vaccine supply before EMA recommendation. Others could follow suit with supply a constraint.

The U.S. dollar is also in focus.

The EU continues to disappoint with low vaccination rates, while Brazil and India begin vaccination drives to bring the pandemic under control.

COVID-19 vaccination rates remain low across the EU. The EMA looks to fast track the authorization of the AstraZeneca vaccine to ramp up vaccinations.

China’s Sinovac vaccine comes under scrutiny following clinical trial results from Brazil. Johnson & Johnson remains on track, however, to deliver a single dose vaccine in Q1.